{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dexamethasone+Pill", "query": { "intervention": "Dexamethasone Pill" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 29, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dexamethasone+Pill&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-06T11:53:15.359Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05488847", "title": "Opioid-Free Pain Protocol After Shoulder Arthroplasty", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Shoulder Arthropathy", "Shoulder Pain" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Ropivicaine", "type": "DRUG" }, { "name": "Epinephrine", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Tizanidine", "type": "DRUG" }, { "name": "Magnesium", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Oxycodone Hydrochloride 5 Mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 83, "start_date": "2022-06-25", "completion_date": "2026-09-01", "has_results": true, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-09-06T11:53:15.359Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05488847" }, { "nct_id": "NCT01670097", "title": "Dexamethasone Dyspnea Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Advanced Cancers", "Hematologic Disorder", "Solid Tumors" ], "interventions": [ { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Questionnaires", "type": "BEHAVIORAL" }, { "name": "Spirometer", "type": "DEVICE" }, { "name": "Phone Calls", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "DEVICE", "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 52, "start_date": "2013-01", "completion_date": "2021-01-26", "has_results": true, "last_update_posted_date": "2021-02-17", "last_synced_at": "2026-09-06T11:53:15.359Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01670097" }, { "nct_id": "NCT05911321", "title": "Isa-Pom-Dex in Elderly/Frail Subjects With RRMM", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Myeloma", "Relapse", "Refractory", "Aging", "Co-morbidity" ], "interventions": [ { "name": "Isatuximab", "type": "DRUG" }, { "name": "Pomalidomide", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UNC Lineberger Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2023-12-05", "completion_date": "2028-03-26", "has_results": true, "last_update_posted_date": "2026-06-09", "last_synced_at": "2026-09-06T11:53:15.359Z", "location_count": 2, "location_summary": "Chapel Hill, North Carolina • Winston-Salem, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05911321" }, { "nct_id": "NCT00584168", "title": "Using Dexamethasone After Uvulopalatopharyngoplasty", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Oklahoma", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2005-03", "completion_date": "2011-12", "has_results": false, "last_update_posted_date": "2012-02-02", "last_synced_at": "2026-09-06T11:53:15.359Z", "location_count": 2, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT00584168" }, { "nct_id": "NCT02402543", "title": "Pre-Emptive Analgesia in Ano-Rectal Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hemorrhoids", "Fissure in Ano", "Rectal Fistula", "Anal Condyloma" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Ketamine", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Vermont", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2014-06", "completion_date": "2017-05", "has_results": false, "last_update_posted_date": "2018-01-16", "last_synced_at": "2026-09-06T11:53:15.359Z", "location_count": 2, "location_summary": "Burlington, Vermont • Colchester, Vermont", "locations": [ { "city": "Burlington", "state": "Vermont" }, { "city": "Colchester", "state": "Vermont" } ], "official_url": "https://clinicaltrials.gov/study/NCT02402543" }, { "nct_id": "NCT01729338", "title": "Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "Velcade", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Revlimid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2012-12-19", "completion_date": "2016-12-31", "has_results": true, "last_update_posted_date": "2017-05-31", "last_synced_at": "2026-09-06T11:53:15.359Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01729338" }, { "nct_id": "NCT06780202", "title": "Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Foot Injuries and Disorders", "Ankle Injuries and Disorders", "Achilles Tendon Injury" ], "interventions": [ { "name": "medrol dosepak", "type": "DRUG" }, { "name": "HYDROcodone Oral Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "18 Years to 95 Years" }, "enrollment_count": 180, "start_date": "2025-01-27", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-03-09", "last_synced_at": "2026-09-06T11:53:15.359Z", "location_count": 2, "location_summary": "Atlanta, Georgia • Johns Creek, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Johns Creek", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06780202" }, { "nct_id": "NCT03142893", "title": "Hormonal Mechanisms of Sleep Restriction - Axis Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Sleep Restriction" ], "interventions": [ { "name": "Ketoconazole Pill", "type": "DRUG" }, { "name": "Ganirelix", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Dexamethasone Injection", "type": "DRUG" }, { "name": "Cosyntropin Injectable Product", "type": "DRUG" }, { "name": "Recombinant Human Luteinizing Hormone", "type": "DRUG" }, { "name": "Hydrocortisone Injection", "type": "DRUG" }, { "name": "Gonadorelin", "type": "DRUG" }, { "name": "Corticorelin", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" }, { "name": "Saline Solution", "type": "DRUG" }, { "name": "Saline Solution for Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Peter y. Liu", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "22 Years to 45 Years · Male only" }, "enrollment_count": 80, "start_date": "2017-05-08", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2025-09-11", "last_synced_at": "2026-09-06T11:53:15.359Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03142893" }, { "nct_id": "NCT05560399", "title": "A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "Iberdomide", "type": "DRUG" }, { "name": "Elotuzumab", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2023-02-06", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-01-02", "last_synced_at": "2026-09-06T11:53:15.359Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05560399" }, { "nct_id": "NCT00572169", "title": "UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "Velcade", "type": "DRUG" }, { "name": "Thalidomide", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Adriamycin", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Arkansas", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 177, "start_date": "2006-11", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-02-05", "last_synced_at": "2026-09-06T11:53:15.359Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00572169" } ] }